Channel
AI models, clinical data infrastructure, imaging, diagnostics and workflow automation across healthcare settings.
In-depth analysis of the current status of AI realizing commercial value in the healthcare sector. This article examines how AI drives returns on investment in core fields such as medical imaging and drug discovery from the perspectives of enterprise applications, technological trends, and market impact.
In-depth analysis of how the medical industry is moving AI from experimentation to implementation, exploring the driving forces behind generative AI and open-source models, as well as the return on investment (ROI) for medical AI in core fields such as imaging and drug discovery.
In-depth analysis of how AI technology is reshaping the healthcare sector, covering AI applications in diagnosis and drug development, key market trends, and regulatory challenges, providing a forward-looking perspective for the medical technology industry.
In-depth analysis of how the global healthcare industry can leverage AI technology to achieve investment returns, covering the latest trends and capital flows in the digital health, AI in healthcare, and medical device sectors.
In-depth analysis of the core applications of medical AI in diagnostic assistance, drug discovery, and digital health platforms, exploring its driving role in the medical equipment and health technology industries, and examining regulatory challenges.
In-depth analysis of the current application status, key technological development trends, and regulatory challenges faced by AI in the healthcare sector (Digital Health, Medical Devices, Biotech Innovation), and exploring how technology drives changes in the medical system.
In-depth analysis of how medical AI technology achieves significant return on investment by improving the efficiency of medical imaging diagnosis and drug development. Focusing on the industry implementation trends of Digital Health and Medical AI.
This article analyzes the implementation progress of AI healthcare, enterprise strategies, market impact, regulatory challenges, and development trends over the next 3-5 years from the perspective of global medical technology industry media, helping industry readers grasp the pulse of Healthcare Innovation.
This article is based on Salesforce's latest industry insights, analyzing the core applications, industry trends, market impact, and potential challenges of AI in healthcare, and exploring the industrial path of medical AI evolving from an assistive tool to healthcare system infrastructure.
Medical AI has moved from experimentation to clinical practice, but the practical application of diagnosis, treatment, and decision support still faces challenges in data, trust, and integration. This article reviews the current state and future trends.
This article analyzes the application of AI in the healthcare industry from an industrial perspective, focusing on how CRM platforms represented by Salesforce drive digital transformation in healthcare through AI agents, data integration, and patient relationship management, while also exploring development trends over the next 3-5 years.
AI, predictive modeling, and human-relevant data are transforming drug safety assessment, reducing reliance on animal testing, and improving predictive accuracy. This article analyzes technological advances, industry impacts, and future trends.
AI is reshaping the healthcare industry, from diagnostic assistance to patient management, with technology implementation accelerating. This article analyzes key trends, market impacts, and future challenges.
A comprehensive analysis of AI in healthcare adoption statistics for 2025-2026, covering market size, ROI, FDA clearances, and the widening gap between administrative and clinical diagnostic use.
Discuss the impact of AI on employment in the healthcare industry, analyzing which positions are at risk, which are safe, and the new opportunities created by AI.
A recent survey by the ZS Impact Institute shows that 58% of American patients research their symptoms using AI or search engines before seeing a doctor, and 18% have directly used AI tools. The healthcare system is facing pressure from the transformation of patient behavior.
Artificial intelligence is accelerating drug development for central nervous system diseases. Insilico Medicine and SK Biopharmaceuticals announced a collaboration to discover neuroimmune drug candidates using Insilico's Pharma.AI platform, with potential milestone payments of up to $2.5 billion.
Medical AI is moving from single prediction to a new stage of integrating predictive and generative AI. By embedding into clinical workflows and adopting hybrid infrastructure, it helps medical institutions transform data insights into actionable clinical actions, improving patient outcomes and reducing the burden on doctors.
Artificial intelligence is revolutionizing decision-making in the biopharmaceutical industry. From drug discovery to clinical trials, AI not only accelerates processes but also forces companies to rethink how to integrate data, expert judgment, and governance structures. This article provides an in-depth analysis of the industry impact and future direction of this trend.
GE HealthCare will showcase AI software, imaging systems, radiopharmaceuticals, and localized production solutions related to nuclear medicine during SNMMI 2026, reflecting that nuclear medicine is moving from competition among single devices toward a phase of expansion driven by “platformization + ecosystemization.”